Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Lan-Lan Smith, Editor-in-Chief, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemol ...
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
All Talk Oncology is a Cancer Podcast that empowers cancer patients through insightful conversations that reinforces confidence and certainty about their cancer condition. Transforming a terrifying experience into a manageable one, by arming patients with the understanding they need, and the ability to take control of their treatments through knowledge, allowing effective interaction with their medical team.
…
continue reading
Medical Breakthroughs features the newest medical advancements in the areas of oncology, cardiology, neurosciences, orthopedics, and genetics featuring America’s leading physicians and medical researchers from Penn Medicine.
…
continue reading
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.Our programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empo ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
In Start Somewhere, Sara Vaughan talks to some of the inspiring people that she's lucky enough to meet in the course of her work, each with their own unique story of how they started somewhere. Follow Sara Vaughan on Twitter @SaraVaughan and Instagram @saravaughanofficial. Contact: sara@saravaughan.me Produced by Front Ear Podcasts https://www.frontearpodcasts.com Edited by Nathan Copelin Music by David Cantello Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
Oncology On The Go is a biweekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY. Each episode, you'll hear from one of the authors of our featured article to summarize the important takeaways from that piece. Then, an outside expert will give their perspective on the details of that article. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, ...
…
continue reading
Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00166-2?dgcid=buzzsprout_tlv_podcast_generic_lanhae Continue this conversation o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
18:21
18:21
Play later
Play later
Lists
Like
Liked
18:21
In a special co-branded episode between Oncology On the Go and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, Rahul Banerjee, MD, FACP, and Noopur Raje, MD, discussed the risk of secondary malignancies in patients with multiple myeloma who receive CAR T-cell therapy. Banerjee is an assistant professor i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Losing a Husband to Saving Her Son: Michael and Ashlee Cramer's Cancer Journey | Ep. 59
55:06
55:06
Play later
Play later
Lists
Like
Liked
55:06
In this conversation, we sit down with Michael and Ashlee Cramer, a mother and son from Florida who faced unimaginable challenges. Michael, diagnosed with rare Hepatosplenic T-cell lymphoma at 19, defied the odds with the support of his mother, Ashlee, who became his full-time caregiver. Together, they endured intense treatments and a recent battle…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ROS1-Alterations and Molecular Testing in Advanced NSCLC
16:28
16:28
Play later
Play later
Lists
Like
Liked
16:28
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
11:56
11:56
Play later
Play later
Lists
Like
Liked
11:56
In a conversation with CancerNetwork®, Brian A. Van Tine, MD, PhD, spoke about the FDA accelerated approval of afamitresgene autoleucel (afami-cel; Tecelra) for patients with metastatic or unresectable synovial sarcoma expressing MAGE-A4. He discussed the data from the phase 2 SPEARHEAD-1 trial (NCT04044768) supporting the agent’s use in this patie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
8:08
8:08
Play later
Play later
Lists
Like
Liked
8:08
Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients. Continue this conversation on social! Follow us today at... https://twitter.com/thelan…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
10:56
10:56
Play later
Play later
Lists
Like
Liked
10:56
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles H…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
1:34:03
1:34:03
Play later
Play later
Lists
Like
Liked
1:34:03
- Overview of ASCO’s 2024 Theme – The Art and Science of Cancer from Comfort to Cure- Updates on the Treatment of Breast Cancer Presented at ASCO- Updates on the Treatment of Ovarian Cancer Presented at ASCO- The Role of Clinical Trials: How Research Increases Treatment Options- Updates on the Treatment of Prostate Cancer Presented at ASCO- Talking…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
13:49
13:49
Play later
Play later
Lists
Like
Liked
13:49
In a conversation with CancerNetwork®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer. Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies and a Lavine Family Chair for Preventative Cancer Therapies at Dana-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Cooking Up a Cure with Chloë Crampton | EP 58
42:12
42:12
Play later
Play later
Lists
Like
Liked
42:12
In this episode, we sit down with Chloë Crampton from London, England, UK, a former actress turned chef and nutrition coach. Chloë bravely shares her personal battle with triple-negative breast cancer, offering hope and inspiration to others facing similar challenges. Discover how she transformed her life after her diagnosis, focusing on healing th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Judy Truong on ferritin reference levels and iron deficiency
11:17
11:17
Play later
Play later
Lists
Like
Liked
11:17
Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS235…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy
28:08
28:08
Play later
Play later
Lists
Like
Liked
28:08
CancerNetwork® spoke with Kamran Idrees, MD, MSCI, MMHC, FACS; Natalie A. Lockney, MD; and Milad Baradaran, PhD, DABR, about the potential utility of intraoperative radiation therapy (IORT) among patients with pancreatic cancer. The group detailed the design and mechanism, gradual technical advancements, and trial data supporting the application of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
49:32
49:32
Play later
Play later
Lists
Like
Liked
49:32
In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma
15:37
15:37
Play later
Play later
Lists
Like
Liked
15:37
In a conversation with CancerNetwork®, Nausheen Ahmed, MD, spoke about optimizing monitoring strategies for patients with B-cell non-Hodgkin lymphoma who undergo treatment with CAR T-cell therapy. Ahmed, an associate professor in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, discussed…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
34:45
34:45
Play later
Play later
Lists
Like
Liked
34:45
In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy
9:57
9:57
Play later
Play later
Lists
Like
Liked
9:57
At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with various experts in the kidney cancer field about potential advancements in disease detection and updated efficacy data on immunotherapy and other treatment strategies in patients with renal cell carcinoma (RCC). Karl Semaan, MD, MSc, a postdoctoral oncology research fellow …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Current Clinical Practice and NCCN Guidelines for CLL/SLL
31:33
31:33
Play later
Play later
Lists
Like
Liked
31:33
In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML
14:11
14:11
Play later
Play later
Lists
Like
Liked
14:11
Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00065…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Battling Follicular Lymphoma with Resilience and Hope with Susete Ferreira | EP 57
56:55
56:55
Play later
Play later
Lists
Like
Liked
56:55
In this episode, we speak with Susete Ferreira, a Toronto-based cancer warrior originally from Portugal. Susete shares her incredible journey from initially mistaking cancer symptoms for menopause to being diagnosed with stage 4 follicular lymphoma, a type of blood cancer. Despite the intense pain and challenges, Susete's positivity and resilience …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field
19:14
19:14
Play later
Play later
Lists
Like
Liked
19:14
As part of the Breaking Barriers: Women in Oncology program, CancerNetwork® spoke with Julie M. Vose, MD, MBA, and Avyakta Kallam, MD, about the evolution of their careers in the hematology-oncology space, including some of the critical advances and challenges associated with their work in the lymphoma field. Vose is division chief, Neumann M. and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
28:35
28:35
Play later
Play later
Lists
Like
Liked
28:35
In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
24:23
24:23
Play later
Play later
Lists
Like
Liked
24:23
In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
24:30
24:30
Play later
Play later
Lists
Like
Liked
24:30
In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence from the monarchE and NATALEE trials of adjuvant abemacicli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma
13:01
13:01
Play later
Play later
Lists
Like
Liked
13:01
Tycel Phillips, MD, spoke with CancerNetwork® ahead of the FDA’s accelerated approval of epcoritamab-bysp (Epkinly) for patients with relapsed/refractory follicular lymphoma to discuss how this agent may impact the treatment paradigm. Phillips, an associate professor in the Division of Lymphoma and Department of Hematology & Hematopoietic Stem Cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Congress to Clinic: Expert Takeaways on Emerging Data for AML
25:21
25:21
Play later
Play later
Lists
Like
Liked
25:21
In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractor…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
19:19
19:19
Play later
Play later
Lists
Like
Liked
19:19
In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dependent, erythropoietin stimulating agent–naive, very low…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care
31:49
31:49
Play later
Play later
Lists
Like
Liked
31:49
In a conversation with CancerNetwork®, James B. Yu, MD, MHS, FASTRO, and Julian C. Hong, MD, MS, spoke about their study titled AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care, which was published in the May issue of the journal ONCOLOGY®. Yu is a radiation oncologist in the Department of Radiation Oncology at Smilo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Current Perspectives on the Future of Cancer Research
1:13:03
1:13:03
Play later
Play later
Lists
Like
Liked
1:13:03
- Understanding the Future of Cancer Research & Clinical Trials- Increased Focus on Earlier Detection & Treatment of Cancer- Health Care Disparities Research- Enhanced Knowledge of the Molecular Portrait of Cancer- Artificial Intelligence (AI) Driven Approaches for Diagnosis & Treatment of Cancer- Microsatellite Instability (MSI): Mutations in DNA …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Current Perspectives on the Future of Cancer Research
1:13:03
1:13:03
Play later
Play later
Lists
Like
Liked
1:13:03
- Understanding the Future of Cancer Research & Clinical Trials- Increased Focus on Earlier Detection & Treatment of Cancer- Health Care Disparities Research- Enhanced Knowledge of the Molecular Portrait of Cancer- Artificial Intelligence (AI) Driven Approaches for Diagnosis & Treatment of Cancer- Microsatellite Instability (MSI): Mutations in DNA …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Healing Through Nutrition with Alison Tierney | EP 56
58:15
58:15
Play later
Play later
Lists
Like
Liked
58:15
In this episode, we sit down with Alison Tierney, a Milwaukee, Wisconsin-based cancer nutritionist specialist. Alison shares her powerful journey from battling infertility and PCOS to being diagnosed with breast cancer at 33. Despite facing these challenges, she embraced a plant-based diet that transformed her life. Alison discusses how food can be…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024
8:13
8:13
Play later
Play later
Lists
Like
Liked
8:13
At the 2024 European Hematology Association (EHA) Congress, CancerNetwork® spoke with a variety of experts in the hematologic oncology space about optimizing outcomes across different patient populations and subgroups based on updated research they presented at the meeting. Manali Kamdar, MD, an associate professor of medicine-hematology and clinic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
50:57
50:57
Play later
Play later
Lists
Like
Liked
50:57
- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), Including Staging and Grading, In the Context of COVID, Seasonal Flu and RSV- Current Standard of Care, New & Emerging Treatment Approaches- Treatment Options for Relapsed Refractory DLBCL, Including Bispecific Antibodies- Understanding How Bispecific Antibodies Work in the Treatment of Relapsed …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Health Care Disparities May Influence Your Cancer Treatment
59:22
59:22
Play later
Play later
Lists
Like
Liked
59:22
- Disproportionate Burden of COVID & Cancer on People of Color- Social Determinants of Health, Including Languages Spoken & Health Literacy- Influence of the Local & Regional Environment in Which You Live on Your Access to Oncology Care- Effect of COVID on Health Care Systems- How Race May Impact Your Access to Cancer Treatment, Management of Treat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Health Care Disparities May Influence Your Cancer Treatment
59:22
59:22
Play later
Play later
Lists
Like
Liked
59:22
- Disproportionate Burden of COVID & Cancer on People of Color- Social Determinants of Health, Including Languages Spoken & Health Literacy- Influence of the Local & Regional Environment in Which You Live on Your Access to Oncology Care- Effect of COVID on Health Care Systems- How Race May Impact Your Access to Cancer Treatment, Management of Treat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep114: Applying Updated Breast Cancer Findings From ASCO to Clinical Practice
31:19
31:19
Play later
Play later
Lists
Like
Liked
31:19
Following the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Neil M. Iyengar, MD, and Paolo Tarantino, MD, co-hosted a live X Space with CancerNetwork® and discussed the latest trial updates that may impact clinical practice in the breast cancer field. Iyengar is an associate attending physician at Memorial Sloan Kettering Cancer…
…
continue reading
- Understanding Precision Medicine: Overview & Value of Precision Medicine- How Precision Medicine is Different from Targeted Treatments?- Precision Medicine Role’s in Informing Treatment Decisions: Predicting Response to Treatment- The Role of Precision Medicine in Deciding the Treatment for Lung Cancer, Leukemia & Colon Cancer- Talking with Your …
…
continue reading
- Understanding Precision Medicine: Overview & Value of Precision Medicine- How Precision Medicine is Different from Targeted Treatments?- Precision Medicine Role’s in Informing Treatment Decisions: Predicting Response to Treatment- The Role of Precision Medicine in Deciding the Treatment for Lung Cancer, Leukemia & Colon Cancer- Talking with Your …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Taking Your Blood Cancer Adherence Treatment on Schedule
57:54
57:54
Play later
Play later
Lists
Like
Liked
57:54
- Overview of Blood Cancer Treatments- Understanding Treatment Side Effects- Working with Your Health Care Team to Manage Each Treatment Side Effects- Dealing with Blood Cancer Treatments & Other Co-Morbid Health Treatments- Adjusting to Your Blood Cancer Treatment Over Time- The Importance of Taking Your Blood Cancer Treatment on Schedule – Adhere…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Taking Your Blood Cancer Adherence Treatment on Schedule
57:54
57:54
Play later
Play later
Lists
Like
Liked
57:54
- Overview of Blood Cancer Treatments- Understanding Treatment Side Effects- Working with Your Health Care Team to Manage Each Treatment Side Effects- Dealing with Blood Cancer Treatments & Other Co-Morbid Health Treatments- Adjusting to Your Blood Cancer Treatment Over Time- The Importance of Taking Your Blood Cancer Treatment on Schedule – Adhere…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep113: Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval
13:43
13:43
Play later
Play later
Lists
Like
Liked
13:43
In a conversation with CancerNetwork®, Jagoda Misniakiewicz, PharmD, a clinical pharmacy specialist in the Clinical Pharmacy and Outcomes Sciences Department at Hollings Cancer Center of the Medical University of South Carolina, spoke about the use of fruquintinib (Fruzaqla) as a treatment option for those with metastatic colorectal cancer (CRC). T…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Persevering Through A Rare Blood Cancer with Harjeet Kaur | EP 55
50:17
50:17
Play later
Play later
Lists
Like
Liked
50:17
In this inspiring episode, we welcome Harjeet Kaur, a remarkable individual who migrated from India to Canada and faced a rare form of blood cancer. Harjeet shares her powerful journey of diagnosis, treatment, and resilience, offering invaluable insights into her battle with this challenging disease. She opens up about the emotional and physical hu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Best Gems & Highlights of 2023: Part 2 | EP 54
23:50
23:50
Play later
Play later
Lists
Like
Liked
23:50
In Part Two of our series, we dive deeper into the inspiring journeys and insights of cancer patients and survivors from 2023. We highlight their resilience, courage, and triumphs in the face of adversity, celebrating their enduring legacies and the progress made in the fight against cancer. Tune in for heartfelt interviews and moving stories that …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep112: Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology
26:47
26:47
Play later
Play later
Lists
Like
Liked
26:47
In a conversation with CancerNetwork®, Terence T. Sio, MD, MS, discussed how technological advancements in radiation oncology have impacted the modern treatment landscape for patients with non–small cell lung cancer (NSCLC). Sio, a professor of radiation oncology at Mayo Clinic in Phoenix, Arizona, first outlined the use of immunotherapy and other …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep111: Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions
21:37
21:37
Play later
Play later
Lists
Like
Liked
21:37
Through elaborate multidisciplinary collaboration, institutions with National Accreditation Program for Rectal Cancer (NAPRC) standards can deliver a “high level of care” in the surgical treatment of patients with rectal cancer, according to Steven Wexner, MD, PhD, and Arielle Kanters, MD. In a conversation with CancerNetwork®, Wexner and Kanters d…
…
continue reading
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00078-4?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us toda…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Myeloma Patient Expert Q&A: Dr. Ola Landgren
44:15
44:15
Play later
Play later
Lists
Like
Liked
44:15
START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team. In this webinar, Dr. Ola Landgren delves into the emerging and exciting therapies and clinical trials for myeloma, discusses the latest options for relapsed disease, and explores the curren…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 Ep110: Finding a Place for Exercise Oncology in the Treatment of Breast Cancer
25:11
25:11
Play later
Play later
Lists
Like
Liked
25:11
In a conversation with CancerNetwork® at Memorial Sloan Kettering Cancer Center (MSKCC), Neil M. Iyengar, MD, spoke about developments and challenges in his career as a medical oncologist and clinical investigator as well as ongoing research efforts in improving outcomes among patients with breast cancer. Iyengar, a breast oncologist in in the Depa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care
30:42
30:42
Play later
Play later
Lists
Like
Liked
30:42
With the quickly evolving landscape of myeloma treatment and care, it’s important to work with your healthcare team to determine a care plan. In this program, Dr. Omar Nadeem discusses the latest updates in research and clinical trials, the role of new and emerging therapies-- including bispecific antibodies and CAR T-cell therapy--and shares advic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
25:55
25:55
Play later
Play later
Lists
Like
Liked
25:55
In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark EMERALD study that led to FDA approval of elacestrant, the first oral selective estrogen receptor degrader (SERD) for treatment of hormone receptor–positive/HER2-negative metastatic breast canc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Caring for Your Loved One with Cancer
1:00:43
1:00:43
Play later
Play later
Lists
Like
Liked
1:00:43
- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Couples, Partners, Siblings, & Friends- Challenges for Caregivers of Cancer Survivors- Family, Partner, & Friend Communication- Care Coordination Challenges & Tips- Stresses on Family, Partners, Friends, &…
…
continue reading